Author: Hurt, Aeron C; Hui, David S; Hay, Alan; Hayden, Frederick G
Title: Overview of the 3rd isirv-Antiviral Group Conference – advances in clinical management Cord-id: cm61h8z5 Document date: 2014_11_15
ID: cm61h8z5
Snippet: This review highlights the main points which emerged from the presentations and discussions at the 3rd isirv-Antiviral Group Conference - advances in clinical management. The conference covered emerging and potentially pandemic influenza viruses and discussed novel/pre-licensure therapeutics and currently approved antivirals and vaccines for the control of influenza. Current data on approved and novel treatments for non-influenza respiratory viruses such as MERS-CoV, respiratory syncytial virus
Document: This review highlights the main points which emerged from the presentations and discussions at the 3rd isirv-Antiviral Group Conference - advances in clinical management. The conference covered emerging and potentially pandemic influenza viruses and discussed novel/pre-licensure therapeutics and currently approved antivirals and vaccines for the control of influenza. Current data on approved and novel treatments for non-influenza respiratory viruses such as MERS-CoV, respiratory syncytial virus (RSV) and rhinoviruses and the challenges of treating immunocompromised patients with respiratory infections was highlighted.
Search related documents:
Co phrase search for related documents- acid extraction and long duration: 1
- acid extraction and low detection: 1, 2, 3, 4, 5
- acid extraction and low proportion: 1
- acid extraction and low throughput: 1, 2
- acid extraction and lrti patient: 1
Co phrase search for related documents, hyperlinks ordered by date